Hong Kong · Delayed Price · Currency is HKD Shanghai Henlius Biotech Statistics
Total Valuation
HKG:2696 has a market cap or net worth of HKD 37.96 billion. The enterprise value is 40.92 billion.
| Market Cap | 37.96B |
| Enterprise Value | 40.92B |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2696 has 543.49 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 163.43M |
| Shares Outstanding | 543.49M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 11.23% |
| Float | 84.16M |
Valuation Ratios
The trailing PE ratio is 42.03 and the forward PE ratio is 42.35.
| PE Ratio | 42.03 |
| Forward PE | 42.35 |
| PS Ratio | 5.98 |
| PB Ratio | 10.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 22.68 |
| P/OCF Ratio | 19.67 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.38, with an EV/FCF ratio of 24.44.
| EV / Earnings | 45.30 |
| EV / Sales | 6.44 |
| EV / EBITDA | 29.38 |
| EV / EBIT | 43.63 |
| EV / FCF | 24.44 |
Financial Position
The company has a current ratio of 0.68, with a Debt / Equity ratio of 1.08.
| Current Ratio | 0.68 |
| Quick Ratio | 0.46 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | 2.89 |
| Debt / FCF | 2.40 |
| Interest Coverage | 7.48 |
Financial Efficiency
Return on equity (ROE) is 27.54% and return on invested capital (ROIC) is 7.80%.
| Return on Equity (ROE) | 27.54% |
| Return on Assets (ROA) | 4.97% |
| Return on Invested Capital (ROIC) | 7.80% |
| Return on Capital Employed (ROCE) | 12.54% |
| Revenue Per Employee | 1.80M |
| Profits Per Employee | 255,371 |
| Employee Count | 3,515 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.73 |
Taxes
In the past 12 months, HKG:2696 has paid 21.48 million in taxes.
| Income Tax | 21.48M |
| Effective Tax Rate | 2.32% |
Stock Price Statistics
The stock price has increased by +215.35% in the last 52 weeks. The beta is 0.77, so HKG:2696's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | +215.35% |
| 50-Day Moving Average | 76.21 |
| 200-Day Moving Average | 49.67 |
| Relative Strength Index (RSI) | 45.87 |
| Average Volume (20 Days) | 1,465,782 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2696 had revenue of HKD 6.35 billion and earned 903.25 million in profits. Earnings per share was 1.66.
| Revenue | 6.35B |
| Gross Profit | 4.81B |
| Operating Income | 937.93M |
| Pretax Income | 924.73M |
| Net Income | 903.25M |
| EBITDA | 1.31B |
| EBIT | 937.93M |
| Earnings Per Share (EPS) | 1.66 |
Balance Sheet
The company has 1.07 billion in cash and 4.02 billion in debt, giving a net cash position of -2.96 billion or -5.44 per share.
| Cash & Cash Equivalents | 1.07B |
| Total Debt | 4.02B |
| Net Cash | -2.96B |
| Net Cash Per Share | -5.44 |
| Equity (Book Value) | 3.73B |
| Book Value Per Share | 6.87 |
| Working Capital | -1.65B |
Cash Flow
In the last 12 months, operating cash flow was 1.93 billion and capital expenditures -256.02 million, giving a free cash flow of 1.67 billion.
| Operating Cash Flow | 1.93B |
| Capital Expenditures | -256.02M |
| Free Cash Flow | 1.67B |
| FCF Per Share | 3.08 |
Margins
Gross margin is 75.77%, with operating and profit margins of 14.76% and 14.22%.
| Gross Margin | 75.77% |
| Operating Margin | 14.76% |
| Pretax Margin | 14.56% |
| Profit Margin | 14.22% |
| EBITDA Margin | 20.64% |
| EBIT Margin | 14.76% |
| FCF Margin | 26.35% |
Dividends & Yields
HKG:2696 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
| Earnings Yield | 2.38% |
| FCF Yield | 4.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2696 has an Altman Z-Score of 1.28 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.28 |
| Piotroski F-Score | 6 |